Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_assertion type Assertion NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_head.
- NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_assertion description "[MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_provenance.
- NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_assertion evidence source_evidence_curated NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_provenance.
- NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_assertion SIO_000772 18287210 NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_provenance.
- NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_assertion wasDerivedFrom ctd_human-20130708 NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_provenance.
- NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_assertion wasGeneratedBy ECO_0000218 NP27621.RAAks8QL-qXhS0D8HJz-gTkAtoXtFcud3DPMmSN5GLAHE130_provenance.